27651009|t|Symptomatic treatments in Alzheimer's disease in 2016: a study from Memory centers in France.
27651009|a|Cholinesterase inhibitors and memantine are used from 15 years, in Alzheimer's disease. Benefits have been demonstrated according to cognition, activities of daily living, affective symptoms and behavior, and global impression of change. The aims of this paper are: 1) to describe how these treatments are used in France with a sample survey managed by the national federation of the french CMRR; 2) to study data about efficacy, safety, medicoeconomic impacts and how they are used in Europe. 
27651009	26	45	Alzheimer's disease	Disease	MESH:D000544
27651009	124	133	memantine	Chemical	MESH:D008559
27651009	161	180	Alzheimer's disease	Disease	MESH:D000544
27651009	Negative_Correlation	MESH:D008559	MESH:D000544

